Areteia Therapeutics is a startup based in the United States, 3 tracked investors.
Areteia Therapeutics is a startup based in the United States. Brouky records 3 investors associated with the company.
Areteia Therapeutics was a clinical-stage biotechnology company developing oral treatments for respiratory conditions, specifically targeting eosinophilic asthma.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.